Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors

M. Ruggeri; A. Tosetto; F. Palandri; N. Polverelli; M. G. Mazzucconi; C. Santoro; G. Gaidano; M. Lunghi; F. Zaja; Valerio De Stefano; R. Sartori; P. Fazi; F. Rodeghiero

doi:10.1111/jth.12636

Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors

M. Ruggeri
, A. Tosetto
, F. Palandri
, N. Polverelli
, M. G. Mazzucconi
, C. Santoro
, G. Gaidano
, M. Lunghi
, F. Zaja
, Valerio De Stefano
, R. Sartori
, P. Fazi
, F. Rodeghiero

Azienda Sanitaria Ulss 6 Vicenza
Alma Mater Studiorum University of Bologna
University of Rome La Sapienza
University of Eastern Piedmont
University of Udine
Transfusion Service, Castelfranco Veneto Hospital
GIMEMA Data Center

Risultato della ricerca: Contributo in rivista › Articolo

58 Citazioni (Scopus)

Abstract

An increased risk of thrombosis has been reported in primary immune thrombocytopenia (ITP) and with the use of thrombopoietin (TPO) receptor agonists, on the basis of population studies using administrative databases.

Lingua originale	Inglese
pagine (da-a)	1266-1273
Numero di pagine	8
Rivista	Journal of Thrombosis and Haemostasis
Volume	12
DOI	https://doi.org/10.1111/jth.12636
Stato di pubblicazione	Pubblicato - 2014

Keywords

TMP mimetic peptide
epidemiology
immune thrombocytopenic purpura
splenectomy
thrombosis

Accesso al documento

10.1111/jth.12636

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Ruggeri, M., Tosetto, A., Palandri, F., Polverelli, N., Mazzucconi, M. G., Santoro, C., Gaidano, G., Lunghi, M., Zaja, F., De Stefano, V., Sartori, R., Fazi, P., & Rodeghiero, F. (2014). Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors. Journal of Thrombosis and Haemostasis, 12, 1266-1273. https://doi.org/10.1111/jth.12636

@article{4f26bba8ce2d445e8fa0df363edfc295,

title = "Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors",

abstract = "An increased risk of thrombosis has been reported in primary immune thrombocytopenia (ITP) and with the use of thrombopoietin (TPO) receptor agonists, on the basis of population studies using administrative databases.",

keywords = "TMP mimetic peptide, epidemiology, immune thrombocytopenic purpura, splenectomy, thrombosis, TMP mimetic peptide, epidemiology, immune thrombocytopenic purpura, splenectomy, thrombosis",

author = "M. Ruggeri and A. Tosetto and F. Palandri and N. Polverelli and Mazzucconi, \{M. G.\} and C. Santoro and G. Gaidano and M. Lunghi and F. Zaja and \{De Stefano\}, Valerio and R. Sartori and P. Fazi and F. Rodeghiero",

year = "2014",

doi = "10.1111/jth.12636",

language = "English",

volume = "12",

pages = "1266--1273",

journal = "Journal of Thrombosis and Haemostasis",

issn = "1538-7836",

publisher = "Elsevier B.V.",

}

Ruggeri, M, Tosetto, A, Palandri, F, Polverelli, N, Mazzucconi, MG, Santoro, C, Gaidano, G, Lunghi, M, Zaja, F, De Stefano, V, Sartori, R, Fazi, P & Rodeghiero, F 2014, 'Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors', Journal of Thrombosis and Haemostasis, vol. 12, pagg. 1266-1273. https://doi.org/10.1111/jth.12636

TY - JOUR

T1 - Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors

AU - Ruggeri, M.

AU - Tosetto, A.

AU - Palandri, F.

AU - Polverelli, N.

AU - Mazzucconi, M. G.

AU - Santoro, C.

AU - Gaidano, G.

AU - Lunghi, M.

AU - Zaja, F.

AU - De Stefano, Valerio

AU - Sartori, R.

AU - Fazi, P.

AU - Rodeghiero, F.

PY - 2014

Y1 - 2014

N2 - An increased risk of thrombosis has been reported in primary immune thrombocytopenia (ITP) and with the use of thrombopoietin (TPO) receptor agonists, on the basis of population studies using administrative databases.

AB - An increased risk of thrombosis has been reported in primary immune thrombocytopenia (ITP) and with the use of thrombopoietin (TPO) receptor agonists, on the basis of population studies using administrative databases.

KW - TMP mimetic peptide

KW - epidemiology

KW - immune thrombocytopenic purpura

KW - splenectomy

KW - thrombosis

KW - TMP mimetic peptide

KW - epidemiology

KW - immune thrombocytopenic purpura

KW - splenectomy

KW - thrombosis

UR - http://hdl.handle.net/10807/64564

U2 - 10.1111/jth.12636

DO - 10.1111/jth.12636

M3 - Article

SN - 1538-7836

VL - 12

SP - 1266

EP - 1273

JO - Journal of Thrombosis and Haemostasis

JF - Journal of Thrombosis and Haemostasis

ER -

Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo